Rigel Pharmaceuticals, Inc. (RIGL) Under Investigation for Investors over Potential Wrongdoing by Certain Directors
Certain directors of Rigel Pharmaceuticals are under investigation over potential wrongdoing. The investigation was announced on behalf of current long-term investors in NASDAQ:RIGL shares concnering potential breaches of fiduciary duties by certain directors at Rigel Pharmaceuticals.
View full press release